REGULATORY INTELLIGENCE TERMINAL
A source-first view of federal actions, their documented company exposure, and the news that matters next.
01 / VERIFIED FEED
The agency approved the first U.S. plasmid DNA-based immunotherapy for adults with recurrent respiratory papillomatosis. FDA names Inovio Pharmaceuticals as the approval recipient; Inovio’s SEC filing confirms Nasdaq ticker INO.
FDA action ↗ Ticker evidence ↗DOJ and EEOC announced a fund of up to $4 million for affected applicants plus a $1 million civil penalty. Maplebear’s SEC filing confirms Instacart and Nasdaq ticker CART.
DOJ release ↗ Ticker evidence ↗DOJ says the order requires integrations with rival tools, data sharing, anti-discrimination safeguards, and six years of oversight. Alphabet’s SEC filing confirms GOOGL and GOOG.
DOJ action ↗ Ticker evidence ↗02 / THE DOCKET STANDARD
Every published item carries an agency link, publication timestamp, evidence note, and confidence state. “Unknown” is a valid result.
Primary federal source collected.
Company exposure tied to evidence.
Edition released at a fixed CT window.
03 / DAILY BRIEFING
One concise morning edition, built for operators who need the source and the consequence.